Market Overview

Benzinga's Volume Movers

Related ECYT
Why Endocyte Could Be Positioned For A Surge
Benzinga's Top Downgrades
Related MRK
Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines
These 4 Charts Highlight Twitter Sentiment For Today's Movers
Making Money With Charles Payne: 12/8/14 (Fox Business)

Endocyte (NASDAQ: ECYT) shares moved up 98.63% to $29.08. The volume of Endocyte shares traded was 4678% higher than normal. Merck & Co (NYSE: MRK) and Endocyte announced the European CHMP positive opinions for VYNFINIT and the companion agents FOLCEPRI and NEOCEPRI.

LIN Media LLC (NYSE: LIN) shares rose 23.36% to $26.51. The volume of LIN Media shares traded was 718% higher than normal. Media General (NYSE: MEG) announced its plans to buy Lin Media LLC for $1.6 billion.

ANN (NYSE: ANN) shares climbed 13.70% to $42.33. The volume of ANN shares traded was 317% higher than normal. Golden Gate Capital disclosed a 9.5% stake in the company.

United Technologies (NYSE: UTX) surged 1.64% to $115.64. The volume of United Technologies shares traded was 280% higher than normal. Goldman Sachs upgraded United Tech from Neutral to Buy and raised the price target from $123.00 to $138.00.

Posted-In: volume moversNews Intraday Update Markets Movers

 

Related Articles (ANN + ECYT)

Around the Web, We're Loving...

Get Benzinga's Newsletters